Citation only
via OpenAlex
Dystrophic microglia in late‐onset Alzheimer's disease
Wolfgang J. Streit, Habibeh Khoshbouei, Ingo Bechmann
Glia · 2020 · ▲ 152 citations
Abstract
Here, we summarize current understanding of functional involvement of microglial cells in the most common neurodegenerative disease to affect humans, which is sporadic or late-onset Alzheimer's disease (LOAD). Our review narrowly focuses on insights obtained from post-mortem neuropathological examinations of human brains paying particular attention to microglia as these cells have long been implicated as pivotal players in the cellular processes that lead to AD-type neurodegeneration. Although complete understanding of the roles played by microglia in AD neurodegeneration remains elusive, our studies thus far have illuminated microglial involvement in LOAD, showing that microglial dystrophy, the morphological manifestation of senescence(definition), can be integrated with other hallmark pathological features of AD, such as intraneuronal neurofibrillary degeneration (NFD) and extracellular deposits of amyloid-beta (Aβ) protein. We have demonstrated an in situ correlation between microglial dystrophy and presence of NFD suggesting that neurodegeneration is secondary to aging-related microglial deterioration, a concept founded on the notion that proper neuronal function is dependent on presence of healthy microglia. Diseased or weakened glia are detrimental for neuronal well-being because their ability to provide neuronal support may be impaired. Our most recent work also links microglial dystrophy with Aβ deposits by showing that there is a chronic, yet futile microglial reaction to insoluble amyloid deposits. This inability of microglia to remove aggregated amyloid (a foreign body) causes microglial exhaustion and thereby exacerbates already ongoing aging-dependent microglial deterioration. An eventual total loss of functional microglia in advanced LOAD promotes widespread NFD, dementia, and brain failure.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/glia.23782
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
Streit, W.J., Khoshbouei, H., & Bechmann, I. (2020). Dystrophic microglia in late‐onset Alzheimer's disease. <em>Glia</em>. https://doi.org/10.1002/glia.23782
Vancouver
Streit WJ, Khoshbouei H, Bechmann I. Dystrophic microglia in late‐onset Alzheimer's disease. Glia. 2020. doi:10.1002/glia.23782.
BibTeX
@article{wolfgang2020Dystro,
title = {Dystrophic microglia in late‐onset Alzheimer's disease},
author = {Wolfgang J. Streit and Habibeh Khoshbouei and Ingo Bechmann},
journal = {Glia},
year = {2020},
doi = {10.1002/glia.23782},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Rejuvenation Research 2007
Citation only
Evidence That Aging And Amyloid Promote Microglial Cell Senescence
Glia 2008
Citation only
Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity
Current Issues in Molecular Biology 2025
Open access · CC-BY
Protein Misfolding and Aggregation as a Mechanistic Link Between Chronic Pain and Neurodegenerative Diseases
Acta Neuropathologica 2009
Open access · CC-BY
Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease
Farmacja Polska 2021
Open access · CC-BY
Neurodegeneration and the pharmacotherapeutic aspect of Alzheimer's disease
Sociedad Española de Neumología y Cirugía Torácica 2015
Open access · US-GOV